AASLD: American Association for the Study of Liver Diseases
Home | Contact Us
About Us | News | JoinPatients | AASLD Foundation | Special Interest Groups | Committees
 

Secretary 2013-2015 
|

Gary L. DavisGary L Davis, MD, FACP 
Baylor University Medical Center 
Dallas, TX

Dr. Davis is the Director of General and Transplant Hepatology for the Baylor Healthcare System and Baylor University Medical Center. He received his medical degree from the University of the Minnesota in Minneapolis. He completed his training in internal medicine and an NIH-funded research fellowship in Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota where he did basic research on hepatitis B virus and clinical research on autoimmune hepatitis. He then moved to Bethesda as a fellow in the Liver Diseases Section of NIDDK at the National Institutes of Health (NIH) under the mentorship of Dr. Jay Hoofnagle. His research focus in Bethesda changed from hepatitis B to hepatitis C, then non-A, non-B hepatitis. Dr. Davis joined the faculty at the University of Florida in 1984 where he founded and directed the Section of Hepatobiliary Diseases and co-founded and directed their liver transplant program. He rose to the rank of Professor of Medicine. In 2002, he moved to Dallas, Texas as Medical Director of Liver Transplantation and to establish a Hepatology division, now one of the largest transplant Hepatology groups in the country. He has trained in administration and leadership at the University of Wisconsin and Southern Methodist University (SMU) in Dallas.

Dr. Davis' research has focused mainly on hepatitis C treatment since he led some of the earliest interferon treatment trials in the 1980s. He has remained active in clinical research with new antivirals and foresees a time in the near future when hepatitis C will be curable in all treated patients. He also has a particular interest in how changing disease demographics impact healthcare resource utilization.

Dr. Davis has authored 300 articles, book chapters, and review papers. He has written chapters on hepatitis C in most of the major textbooks in Hepatology, gastroenterology and liver transplantation. He serves on several Baylor committees and boards, and has been active in UNOS in the past. Dr. Davis has been a member of the AASLD for almost 30 years, has attended the annual meetings since 1979, and has served on many of the Association's committees. He has previously served on the Governing Board as Councilor-at-Large.

Conflict of Interest
Dr. Gary L. Davis has served on the advisory board for Genentech. He also serves on the Data Safety Monitoring Board for BMS and Duke/Gilead.